{"id":"radium-bromatum-pills","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Bone marrow suppression"},{"rate":"10-20%","effect":"Nausea and vomiting"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2107816","moleculeType":"Small molecule","molecularWeight":"293.92"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Radium bromatum pills contain radium-224, a radioactive isotope that decays into other radioactive isotopes, which then emit ionizing radiation to kill cancer cells. This process is known as brachytherapy, where a radioactive source is placed inside or next to the tumor to deliver a high dose of radiation directly to the cancer cells.","oneSentence":"Radium bromatum pills work by emitting ionizing radiation to kill cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:09.689Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of bone cancer"}]},"trialDetails":[{"nctId":"NCT03753776","phase":"PHASE3","title":"Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2019-07-15","conditions":"Breast Cancer","enrollment":232}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Radium bromatum"],"phase":"phase_3","status":"active","brandName":"Radium bromatum pills","genericName":"Radium bromatum pills","companyName":"Centre Hospitalier Universitaire de Saint Etienne","companyId":"centre-hospitalier-universitaire-de-saint-etienne","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Radium bromatum pills are a small molecule with a mechanism as a radiotherapy agent, classified as a small molecule modality. They have been studied in a Phase III trial on ClinicalTrials.gov for the prevention and treatment of radiodermatitis in breast cancer patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}